SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001615774-18-009476
Filing Date
2018-09-12
Accepted
2018-09-12 16:32:32
Documents
2
Group Members
VIVO CAPITAL IX, LLCVIVO OPPORTUNITY, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G s112671_sc13g.htm SC 13G 112893
2 EXHIBIT 99.1 s112671_ex99-1.htm EX-99.1 6040
  Complete submission text file 0001615774-18-009476.txt   120841
Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Subject) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: SC 13G | Act: 34 | File No.: 005-88797 | Film No.: 181067135
SIC: 2834 Pharmaceutical Preparations

Mailing Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301 (650) 688-0818
Vivo Ventures VI, LLC (Filed by) CIK: 0001469547 (see all company filings)

IRS No.: 208829402 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G